3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
2
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
Cisplatin
13
Paclitaxel
12
pembrolizumab
8
Fluorouracil
7
Radiotherapy
5
Irinotecan
5
Esophagectomy
5
toripalimab
4
tislelizumab
4
Oxaliplatin
4
Leucovorin
4
Carboplatin
4
Radiation
3
Levoleucovorin
3
Drug Therapy
3
Docetaxel
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
camrelizumab
2
Taxes
2
Nivolumab
2
Injections
2
spartalizumab
1
sintilimab
1
palbociclib
1
nazartinib
1
lenvatinib
1
ivarmacitinib
1
futibatinib
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
TP protocol
×
90 days
×
Clear all
NCT06143748
2026-04-23
EC-CRT-006
Sun Yat-sen University
Phase 2
Active not recruiting
46 enrolled